Review3 Biotech2021
A review on enzymes and pathways for manufacturing polyhydroxybutyrate from lignocellulosic materials.
Review in 3 Biotech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Sustainable Green Polymer Production for Pharmaceutical Manufacturing: A Review of Environmental and Economic Impacts.Polymers · 2026Review
- Valorization of Dried Okara Hydrolysate for Polyhydroxybutyrate Production by Newly IsolatedBioengineering (Basel, Switzerland) · 2026Article
- Enhancing stability of enzymes for industrial applications: molecular insights and emerging approaches.World journal of microbiology & biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, major focus in the biopolymer field is being drawn on the exploitation of plant-based resources grounded on holistic sustainability trends to produce novel, affordable, biocompatible and environmentally safe polyhydroxyalkanoate biopolymers. The global PHA market, estimated at USD 62 Million in 2020, is predicted to grow by 11.2 and 14.2% between 2020-2024 and 2020-2025 correspondingly based on market research reports. The market is primarily driven by the growing demand for PHA products by the food packaging, biomedical, pharmaceutical, biofuel and agricultural sectors. One of the key limitations in the growth of the PHA market is the significantly higher production costs associated with pure carbon raw materials as compared to traditional polymers. Nonetheless, considerations such as consumer awareness on the toxicity of petroleum-based plastics and strict government regulations towards the prohibition of the use and trade of synthetic plastics are expected to boost the market growth rate. This study throws light on the production of polyhydroxybutyrate from lignocellulosic biomass using environmentally benign techniques via enzyme and microbial activities to assess its feasibility as a green substitute to conventional plastics. The novelty of the present study is to highlight the recent advances, pretreatment techniques to reduce the recalcitrance of lignocellulosic biomass such as dilute and concentrated acidic pretreatment, alkaline pretreatment, steam explosion, ammonia fibre explosion (AFEX), ball milling, biological pretreatment as well as novel emerging pretreatment techniques notably, high-pressure homogenizer, electron beam, high hydrostatic pressure, co-solvent enhanced lignocellulosic fractionation (CELF) pulsed-electric field, low temperature steep delignification (LTSD), microwave and ultrasound technologies. Additionally, inhibitory compounds and detoxification routes, fermentation downstream processes, life cycle and environmental impacts of recovered natural biopolymers, review green procurement policies in various countries, PHA strategies in line with the United Nations Sustainable Development Goals (SDGs) along with the fate of the spent polyhydroxybutyrate are outlined.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.